At that price, another 100-million-dose order would generation nearly $1.5 billion in sales for BioNTech and Pfizer to split equally. The possibility that BioNTech's revenue could increase even more in the near future is a pretty good reason for the biotech stock to jump today.
Is biontech's stock on the rise?
Vaccine ampoules stand on a table at the Harz Vaccination Centre. (This story is for CNBC PRO subscribers only.) BioNTech’s shares have risen more than 180% in the last 12 months and hit a record high in December, but one analyst from investment bank Berenberg said there’s more upside in the coming year.
What is a Biotech stock?
biotech(Noun) A company specializing in biotechnology, or stock in such a company. A lot of people invested in biotechs, back in the '90s.
